2018-2023 Global Meningococcal Disease Drugs Consumption Market Report

October 2018 | 130 pages | ID: 28C1BCF2524EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Meningococcal Disease Drugs market for 2018-2023.
Meningococcal disease is a severe infection of meninges, the thin layers of tissue covering brain and spinal cord, caused by the bacteria Neisseria meningitidis. This bacteria can also cause bloodstream infections (septicemia). Bacterial meningitis is severe because of rapid onset and a significant risk of death associated with infection. Infection of Neisseria meningitidis may also result in mental retardation, deafness and epilepsy. 12 strains of N. meningitidis have been identified, 6 of which (A, B, C, W, X and Y) are capable enough to cause epidemics. Meningococcal septicaemia is a rare but fatal form of meningococcal disease characterized by a haemorrhagic rash and rapid circulatory collapse.

Over the next five years, LPI(LP Information) projects that Meningococcal Disease Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

This report presents a comprehensive overview, market shares, and growth opportunities of Meningococcal Disease Drugs market by product type, application, key manufacturers and key regions.

To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

Segmentation by product type:

• Injectable
• Oral

Segmentation by application:

• Hospitals
• Drugstores
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Spain
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:

• Pfizer
• GlaxoSmithKline
• Sanofi Pasteur
• Novartis

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

RESEARCH OBJECTIVES

• To study and analyze the global Meningococcal Disease Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
• To understand the structure of Meningococcal Disease Drugs market by identifying its various subsegments.
• Focuses on the key global Meningococcal Disease Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
• To analyze the Meningococcal Disease Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Meningococcal Disease Drugs submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

2018-2023 GLOBAL MENINGOCOCCAL DISEASE DRUGS CONSUMPTION MARKET REPORT

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Meningococcal Disease Drugs Consumption 2013-2023
  2.1.2 Meningococcal Disease Drugs Consumption CAGR by Region
2.2 Meningococcal Disease Drugs Segment by Type
  2.2.1 Injectable
  2.2.2 Oral
2.3 Meningococcal Disease Drugs Consumption by Type
  2.3.1 Global Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
  2.3.2 Global Meningococcal Disease Drugs Revenue and Market Share by Type (2013-2018)
  2.3.3 Global Meningococcal Disease Drugs Sale Price by Type (2013-2018)
2.4 Meningococcal Disease Drugs Segment by Application
  2.4.1 Hospitals
  2.4.2 Drugstores
  2.4.3 Others
2.5 Meningococcal Disease Drugs Consumption by Application
  2.5.1 Global Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
  2.5.2 Global Meningococcal Disease Drugs Value and Market Share by Application (2013-2018)
  2.5.3 Global Meningococcal Disease Drugs Sale Price by Application (2013-2018)

3 GLOBAL MENINGOCOCCAL DISEASE DRUGS BY PLAYERS

3.1 Global Meningococcal Disease Drugs Sales Market Share by Players
  3.1.1 Global Meningococcal Disease Drugs Sales by Players (2016-2018)
  3.1.2 Global Meningococcal Disease Drugs Sales Market Share by Players (2016-2018)
3.2 Global Meningococcal Disease Drugs Revenue Market Share by Players
  3.2.1 Global Meningococcal Disease Drugs Revenue by Players (2016-2018)
  3.2.2 Global Meningococcal Disease Drugs Revenue Market Share by Players (2016-2018)
3.3 Global Meningococcal Disease Drugs Sale Price by Players
3.4 Global Meningococcal Disease Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
  3.4.1 Global Meningococcal Disease Drugs Manufacturing Base Distribution and Sales Area by Players
  3.4.2 Players Meningococcal Disease Drugs Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 MENINGOCOCCAL DISEASE DRUGS BY REGIONS

4.1 Meningococcal Disease Drugs by Regions
  4.1.1 Global Meningococcal Disease Drugs Consumption by Regions
  4.1.2 Global Meningococcal Disease Drugs Value by Regions
4.2 Americas Meningococcal Disease Drugs Consumption Growth
4.3 APAC Meningococcal Disease Drugs Consumption Growth
4.4 Europe Meningococcal Disease Drugs Consumption Growth
4.5 Middle East & Africa Meningococcal Disease Drugs Consumption Growth

5 AMERICAS

5.1 Americas Meningococcal Disease Drugs Consumption by Countries
  5.1.1 Americas Meningococcal Disease Drugs Consumption by Countries (2013-2018)
  5.1.2 Americas Meningococcal Disease Drugs Value by Countries (2013-2018)
5.2 Americas Meningococcal Disease Drugs Consumption by Type
5.3 Americas Meningococcal Disease Drugs Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries

6 APAC

6.1 APAC Meningococcal Disease Drugs Consumption by Countries
  6.1.1 APAC Meningococcal Disease Drugs Consumption by Countries (2013-2018)
  6.1.2 APAC Meningococcal Disease Drugs Value by Countries (2013-2018)
6.2 APAC Meningococcal Disease Drugs Consumption by Type
6.3 APAC Meningococcal Disease Drugs Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries

7 EUROPE

7.1 Europe Meningococcal Disease Drugs by Countries
  7.1.1 Europe Meningococcal Disease Drugs Consumption by Countries (2013-2018)
  7.1.2 Europe Meningococcal Disease Drugs Value by Countries (2013-2018)
7.2 Europe Meningococcal Disease Drugs Consumption by Type
7.3 Europe Meningococcal Disease Drugs Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Meningococcal Disease Drugs by Countries
  8.1.1 Middle East & Africa Meningococcal Disease Drugs Consumption by Countries (2013-2018)
  8.1.2 Middle East & Africa Meningococcal Disease Drugs Value by Countries (2013-2018)
8.2 Middle East & Africa Meningococcal Disease Drugs Consumption by Type
8.3 Middle East & Africa Meningococcal Disease Drugs Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers and Impact
  9.1.1 Growing Demand from Key Regions
  9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 MARKETING, DISTRIBUTORS AND CUSTOMER

10.1 Sales Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
10.2 Meningococcal Disease Drugs Distributors
10.3 Meningococcal Disease Drugs Customer

11 GLOBAL MENINGOCOCCAL DISEASE DRUGS MARKET FORECAST

11.1 Global Meningococcal Disease Drugs Consumption Forecast (2018-2023)
11.2 Global Meningococcal Disease Drugs Forecast by Regions
  11.2.1 Global Meningococcal Disease Drugs Forecast by Regions (2018-2023)
  11.2.2 Global Meningococcal Disease Drugs Value Forecast by Regions (2018-2023)
  11.2.3 Americas Consumption Forecast
  11.2.4 APAC Consumption Forecast
  11.2.5 Europe Consumption Forecast
  11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
  11.3.1 United States Market Forecast
  11.3.2 Canada Market Forecast
  11.3.3 Mexico Market Forecast
  11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
  11.4.1 China Market Forecast
  11.4.2 Japan Market Forecast
  11.4.3 Korea Market Forecast
  11.4.4 Southeast Asia Market Forecast
  11.4.5 India Market Forecast
  11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
  11.5.1 Germany Market Forecast
  11.5.2 France Market Forecast
  11.5.3 UK Market Forecast
  11.5.4 Italy Market Forecast
  11.5.5 Russia Market Forecast
  11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
  11.6.1 Egypt Market Forecast
  11.6.2 South Africa Market Forecast
  11.6.3 Israel Market Forecast
  11.6.4 Turkey Market Forecast
  11.6.5 GCC Countries Market Forecast
11.7 Global Meningococcal Disease Drugs Forecast by Type
11.8 Global Meningococcal Disease Drugs Forecast by Application

12 KEY PLAYERS ANALYSIS

12.1 Pfizer
  12.1.1 Company Details
  12.1.2 Meningococcal Disease Drugs Product Offered
  12.1.3 Pfizer Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.1.4 Main Business Overview
  12.1.5 Pfizer News
12.2 GlaxoSmithKline
  12.2.1 Company Details
  12.2.2 Meningococcal Disease Drugs Product Offered
  12.2.3 GlaxoSmithKline Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.2.4 Main Business Overview
  12.2.5 GlaxoSmithKline News
12.3 Sanofi Pasteur
  12.3.1 Company Details
  12.3.2 Meningococcal Disease Drugs Product Offered
  12.3.3 Sanofi Pasteur Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.3.4 Main Business Overview
  12.3.5 Sanofi Pasteur News
12.4 Novartis
  12.4.1 Company Details
  12.4.2 Meningococcal Disease Drugs Product Offered
  12.4.3 Novartis Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
  12.4.4 Main Business Overview
  12.4.5 Novartis News

13 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Meningococcal Disease Drugs
Table Product Specifications of Meningococcal Disease Drugs
Figure Meningococcal Disease Drugs Report Years Considered
Figure Market Research Methodology
Figure Global Meningococcal Disease Drugs Consumption Growth Rate 2013-2023 (K Units)
Figure Global Meningococcal Disease Drugs Value Growth Rate 2013-2023 ($ Millions)
Table Meningococcal Disease Drugs Consumption CAGR by Region 2013-2023 ($ Millions)
Figure Product Picture of Injectable
Table Major Players of Injectable
Figure Product Picture of Oral
Table Major Players of Oral
Table Global Consumption Sales by Type (2013-2018)
Table Global Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Global Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
Table Global Meningococcal Disease Drugs Revenue by Type (2013-2018) ($ million)
Table Global Meningococcal Disease Drugs Value Market Share by Type (2013-2018) ($ Millions)
Figure Global Meningococcal Disease Drugs Value Market Share by Type (2013-2018)
Table Global Meningococcal Disease Drugs Sale Price by Type (2013-2018)
Figure Meningococcal Disease Drugs Consumed in Hospitals
Figure Global Meningococcal Disease Drugs Market: Hospitals (2013-2018) (K Units)
Figure Global Meningococcal Disease Drugs Market: Hospitals (2013-2018) ($ Millions)
Figure Global Hospitals YoY Growth ($ Millions)
Figure Meningococcal Disease Drugs Consumed in Drugstores
Figure Global Meningococcal Disease Drugs Market: Drugstores (2013-2018) (K Units)
Figure Global Meningococcal Disease Drugs Market: Drugstores (2013-2018) ($ Millions)
Figure Global Drugstores YoY Growth ($ Millions)
Figure Meningococcal Disease Drugs Consumed in Others
Figure Global Meningococcal Disease Drugs Market: Others (2013-2018) (K Units)
Figure Global Meningococcal Disease Drugs Market: Others (2013-2018) ($ Millions)
Figure Global Others YoY Growth ($ Millions)
Table Global Consumption Sales by Application (2013-2018)
Table Global Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Global Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
Table Global Meningococcal Disease Drugs Value by Application (2013-2018)
Table Global Meningococcal Disease Drugs Value Market Share by Application (2013-2018)
Figure Global Meningococcal Disease Drugs Value Market Share by Application (2013-2018)
Table Global Meningococcal Disease Drugs Sale Price by Application (2013-2018)
Table Global Meningococcal Disease Drugs Sales by Players (2016-2018) (K Units)
Table Global Meningococcal Disease Drugs Sales Market Share by Players (2016-2018)
Figure Global Meningococcal Disease Drugs Sales Market Share by Players in 2016
Figure Global Meningococcal Disease Drugs Sales Market Share by Players in 2017
Table Global Meningococcal Disease Drugs Revenue by Players (2016-2018) ($ Millions)
Table Global Meningococcal Disease Drugs Revenue Market Share by Players (2016-2018)
Figure Global Meningococcal Disease Drugs Revenue Market Share by Players in 2016
Figure Global Meningococcal Disease Drugs Revenue Market Share by Players in 2017
Table Global Meningococcal Disease Drugs Sale Price by Players (2016-2018)
Figure Global Meningococcal Disease Drugs Sale Price by Players in 2017
Table Global Meningococcal Disease Drugs Manufacturing Base Distribution and Sales Area by Players
Table Players Meningococcal Disease Drugs Products Offered
Table Meningococcal Disease Drugs Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
Table Global Meningococcal Disease Drugs Consumption by Regions 2013-2018 (K Units)
Table Global Meningococcal Disease Drugs Consumption Market Share by Regions 2013-2018
Figure Global Meningococcal Disease Drugs Consumption Market Share by Regions 2013-2018
Table Global Meningococcal Disease Drugs Value by Regions 2013-2018 ($ Millions)
Table Global Meningococcal Disease Drugs Value Market Share by Regions 2013-2018
Figure Global Meningococcal Disease Drugs Value Market Share by Regions 2013-2018
Figure Americas Meningococcal Disease Drugs Consumption 2013-2018 (K Units)
Figure Americas Meningococcal Disease Drugs Value 2013-2018 ($ Millions)
Figure APAC Meningococcal Disease Drugs Consumption 2013-2018 (K Units)
Figure APAC Meningococcal Disease Drugs Value 2013-2018 ($ Millions)
Figure Europe Meningococcal Disease Drugs Consumption 2013-2018 (K Units)
Figure Europe Meningococcal Disease Drugs Value 2013-2018 ($ Millions)
Figure Middle East & Africa Meningococcal Disease Drugs Consumption 2013-2018 (K Units)
Figure Middle East & Africa Meningococcal Disease Drugs Value 2013-2018 ($ Millions)
Table Americas Meningococcal Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table Americas Meningococcal Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure Americas Meningococcal Disease Drugs Consumption Market Share by Countries in 2017
Table Americas Meningococcal Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table Americas Meningococcal Disease Drugs Value Market Share by Countries (2013-2018)
Figure Americas Meningococcal Disease Drugs Value Market Share by Countries in 2017
Table Americas Meningococcal Disease Drugs Consumption by Type (2013-2018) (K Units)
Table Americas Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Americas Meningococcal Disease Drugs Consumption Market Share by Type in 2017
Table Americas Meningococcal Disease Drugs Consumption by Application (2013-2018) (K Units)
Table Americas Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Americas Meningococcal Disease Drugs Consumption Market Share by Application in 2017
Figure United States Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure United States Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Canada Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Canada Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Mexico Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Mexico Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Table APAC Meningococcal Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table APAC Meningococcal Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure APAC Meningococcal Disease Drugs Consumption Market Share by Countries in 2017
Table APAC Meningococcal Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table APAC Meningococcal Disease Drugs Value Market Share by Countries (2013-2018)
Figure APAC Meningococcal Disease Drugs Value Market Share by Countries in 2017
Table APAC Meningococcal Disease Drugs Consumption by Type (2013-2018) (K Units)
Table APAC Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
Figure APAC Meningococcal Disease Drugs Consumption Market Share by Type in 2017
Table APAC Meningococcal Disease Drugs Consumption by Application (2013-2018) (K Units)
Table APAC Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
Figure APAC Meningococcal Disease Drugs Consumption Market Share by Application in 2017
Figure China Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure China Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Japan Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Japan Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Korea Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Korea Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Southeast Asia Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Southeast Asia Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure India Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure India Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Australia Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Australia Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Table Europe Meningococcal Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table Europe Meningococcal Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure Europe Meningococcal Disease Drugs Consumption Market Share by Countries in 2017
Table Europe Meningococcal Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table Europe Meningococcal Disease Drugs Value Market Share by Countries (2013-2018)
Figure Europe Meningococcal Disease Drugs Value Market Share by Countries in 2017
Table Europe Meningococcal Disease Drugs Consumption by Type (2013-2018) (K Units)
Table Europe Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Europe Meningococcal Disease Drugs Consumption Market Share by Type in 2017
Table Europe Meningococcal Disease Drugs Consumption by Application (2013-2018) (K Units)
Table Europe Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Europe Meningococcal Disease Drugs Consumption Market Share by Application in 2017
Figure Germany Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Germany Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure France Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure France Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure UK Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure UK Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Italy Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Italy Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Russia Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Russia Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Spain Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Spain Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Table Middle East & Africa Meningococcal Disease Drugs Consumption by Countries (2013-2018) (K Units)
Table Middle East & Africa Meningococcal Disease Drugs Consumption Market Share by Countries (2013-2018)
Figure Middle East & Africa Meningococcal Disease Drugs Consumption Market Share by Countries in 2017
Table Middle East & Africa Meningococcal Disease Drugs Value by Countries (2013-2018) ($ Millions)
Table Middle East & Africa Meningococcal Disease Drugs Value Market Share by Countries (2013-2018)
Figure Middle East & Africa Meningococcal Disease Drugs Value Market Share by Countries in 2017
Table Middle East & Africa Meningococcal Disease Drugs Consumption by Type (2013-2018) (K Units)
Table Middle East & Africa Meningococcal Disease Drugs Consumption Market Share by Type (2013-2018)
Figure Middle East & Africa Meningococcal Disease Drugs Consumption Market Share by Type in 2017
Table Middle East & Africa Meningococcal Disease Drugs Consumption by Application (2013-2018) (K Units)
Table Middle East & Africa Meningococcal Disease Drugs Consumption Market Share by Application (2013-2018)
Figure Middle East & Africa Meningococcal Disease Drugs Consumption Market Share by Application in 2017
Figure Egypt Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Egypt Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure South Africa Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure South Africa Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Israel Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Israel Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure Turkey Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure Turkey Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Figure GCC Countries Meningococcal Disease Drugs Consumption Growth 2013-2018 (K Units)
Figure GCC Countries Meningococcal Disease Drugs Value Growth 2013-2018 ($ Millions)
Table Meningococcal Disease Drugs Distributors List
Table Meningococcal Disease Drugs Customer List
Figure Global Meningococcal Disease Drugs Consumption Growth Rate Forecast (2018-2023) (K Units)
Figure Global Meningococcal Disease Drugs Value Growth Rate Forecast (2018-2023) ($ Millions)
Table Global Meningococcal Disease Drugs Consumption Forecast by Countries (2018-2023) (K Units)
Table Global Meningococcal Disease Drugs Consumption Market Forecast by Regions
Table Global Meningococcal Disease Drugs Value Forecast by Countries (2018-2023) ($ Millions)
Table Global Meningococcal Disease Drugs Value Market Share Forecast by Regions
Figure Americas Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Americas Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure APAC Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure APAC Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Europe Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Europe Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Middle East & Africa Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Middle East & Africa Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure United States Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure United States Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Canada Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Canada Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Mexico Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Mexico Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Brazil Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Brazil Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure China Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure China Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Japan Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Japan Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Korea Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Korea Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Southeast Asia Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Southeast Asia Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure India Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure India Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Australia Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Australia Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Germany Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Germany Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure France Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure France Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure UK Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure UK Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Italy Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Italy Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Russia Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Russia Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Spain Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Spain Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Egypt Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Egypt Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure South Africa Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure South Africa Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Israel Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Israel Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure Turkey Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure Turkey Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Figure GCC Countries Meningococcal Disease Drugs Consumption 2018-2023 (K Units)
Figure GCC Countries Meningococcal Disease Drugs Value 2018-2023 ($ Millions)
Table Global Meningococcal Disease Drugs Consumption Forecast by Type (2018-2023) (K Units)
Table Global Meningococcal Disease Drugs Consumption Market Share Forecast by Type (2018-2023)
Table Global Meningococcal Disease Drugs Value Forecast by Type (2018-2023) ($ Millions)
Table Global Meningococcal Disease Drugs Value Market Share Forecast by Type (2018-2023)
Table Global Meningococcal Disease Drugs Consumption Forecast by Application (2018-2023) (K Units)
Table Global Meningococcal Disease Drugs Consumption Market Share Forecast by Application (2018-2023)
Table Global Meningococcal Disease Drugs Value Forecast by Application (2018-2023) ($ Millions)
Table Global Meningococcal Disease Drugs Value Market Share Forecast by Application (2018-2023)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Pfizer Meningococcal Disease Drugs Market Share (2016-2018)
Table GlaxoSmithKline Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table GlaxoSmithKline Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure GlaxoSmithKline Meningococcal Disease Drugs Market Share (2016-2018)
Table Sanofi Pasteur Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Sanofi Pasteur Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Sanofi Pasteur Meningococcal Disease Drugs Market Share (2016-2018)
Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Novartis Meningococcal Disease Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
Figure Novartis Meningococcal Disease Drugs Market Share (2016-2018)